The US peptide therapeutics market is anticipated to project a CAGR of 5.0%, during the forecast period. The major factor that contributes to the country’s market growth is continuously increasing healthcare spending. According to the Peptide Therapeutics Foundation, the number of new peptides entering the clinic has been doubled in the past decade. Additionally, the four of the US-approved peptides have also achieved global sales over $1 billion. There are more than 54 therapeutic peptides that have been approved across the globe out of which the US has a considerable share of 26 drugs. Such data showcase the substantial growth of the US in the global peptide market.
Get Free Sample link @ https://www.omrglobal.com/request-sample/us-peptide-therapeutics-market
The US peptide therapeutics market is segmented on the basis of route of administration and application. Based on the route of administration, the market is bifurcated into parenteral administration and oral administration. On the basis of application, the market is segmented into cancer, metabolic disorder (diabetes & obesity), gastrointestinal disorders, central nervous system disorders, respiratory disorders, and others including chronic kidney diseases, osteoporosis, and autoimmune disorder. Among these applications, the metabolic disorder dominates the market in the US. The increasing prevalence of diabetes globally created demand for insulin and hence drives the market growth.
A full report of US Peptide Therapeutics Market available @ https://www.omrglobal.com/industry-reports/us-peptide-therapeutics-market
- Market Coverage
- Market number available for – 2022-2028
- Base year- 2021
- Forecast period- 2022-2028
- Segment Covered- By Source, By Product Type, By Applications
- Competitive Landscape- Archer Daniels Midland Co., Ingredion Inc., Kerry Group Plc, Cargill Inc., and others
Market Segmentation
US Peptide Therapeutics Market by Route of Administration
- Oral
- Parenteral
US Peptide Therapeutics Market by Application
- Cancer
- Metabolic Disorder
- Gastrointestinal Disorders
- Central Nervous System Disorders
- Respiratory Disorders
- Others (Kidney Disorder and Autoimmune Disorder)
Company Profiles
- Amgen, Inc.
- Overview
- Amgen Inc. in Peptide Therapeutics Landscape
- Recent Developments
- AstraZeneca PLC
- Bristol Myers Squibb Co.
- Eli Lilly and Co.
- Hoffmann-La Roche Ltd.
- GlaxoSmithKline PLC
- Merck & Co., Inc.
- Novartis International AG
- Novo Nordisk A/S
- Pfizer Inc.
- Sanofi SA
- Xenetic Biosciences, Inc.
The Report covers:
- Comprehensive research methodology of the US peptide therapeutics market.
- This report also includes a detailed and extensive market overview with key analyst insights.
- Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
- Analysis of regional regulations and other government policies impacting the US peptide therapeutics market.
- Insights about market determinants which are stimulating the US peptide therapeutics market.
- Detailed and extensive market segments with regional distribution of forecasted revenues.
- Extensive profiles and recent developments of market players.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/us-peptide-therapeutics-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
